Primary Amyloidosis

hematologic malignancy

Identifier: CI-CAN-00008290
Entity page: /cancer/primary-amyloidosis ↗
Edges: 138

Neighbours: 32 drugs10 trials
Drawn: 42 of 42 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Primary Amyloidosis investigated in trials for …INVESTIGATED_IN_TRIALSderived32 of 32show fewer
→ investigated in trials for	Dexamethasonesmall molecule 24 trials (8 active) · roll-up of the cancer and its descendants	—	—	Primary Amyloidosis	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal antibody 10 trials (6 active) · roll-up of the cancer and its descendants

Primary Amyloidosis studied in …STUDIED_INderived10 of 106show all (up to 200)
→ studied in	NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ALIAS · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07172243recruiting BE.Amycon Biobank & Data Registry UZ Leuven · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07215494NA · recruiting A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis · condition mapped ALIAS · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07103863enrolling by invitation Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07615270early Phase 1 · not yet recruiting A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05145816Phase 1/Phase 2 · recruiting Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT06569147Phase 1/Phase 2 · recruiting Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07751471Phase 2 · not yet recruiting BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004) · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05184088Phase 3 · completed Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07638683Phase 2 · recruiting A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). · condition mapped ONTOLOGY_EXACT · 106 trials mapped (45 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains